Literature DB >> 2216455

Specific expression of the ret proto-oncogene in human neuroblastoma cell lines.

I Ikeda1, Y Ishizaka, T Tahira, T Suzuki, M Onda, T Sugimura, M Nagao.   

Abstract

The expression of the ret proto-oncogene (proto-ret), which possibly encodes two isoforms of a receptor-type tyrosine kinase, was examined in human tumor cell lines. Expression of the proto-ret mRNA was detected in all 11 neuroblastoma cell lines examined. The level of mRNA varied more than 100-fold in these neuroblastoma cell lines and was particularly high in three of them. On the other hand, 19 non-neuroblastoma tumor cell lines derived from solid tumors and a human diploid fibroblast cell line did not express any detectable levels of proto-ret mRNA. No remarkable amplification of the proto-ret or gross structural changes in the coding region were found in these neuroblastoma cell lines. The specific expression of the proto-ret in neuroblastomas suggests that the proto-ret product may have a role in cellular functions specific to neuroblastoma cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2216455

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism.

Authors:  M P Cosma; M Cardone; F Carlomagno; V Colantuoni
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 2.  Oncogenes and anti-oncogenes in human epithelial thyroid tumors.

Authors:  S Said; M Schlumberger; H G Suarez
Journal:  J Endocrinol Invest       Date:  1994-05       Impact factor: 4.256

3.  No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma.

Authors:  R M Hofstra; N C Cheng; C Hansen; R P Stulp; T Stelwagen; N Clausen; N Tommerup; H Caron; A Westerveld; R Versteeg; C H Buys
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

4.  RET-protooncogene variants in patients with sporadic neoplasms of the digestive tract and the central nervous system.

Authors:  Felix Rückert; Heike Görgens; Ines Richter; Dietmar Krex; Gabriele Schackert; Eberhard Kuhlisch; Guido Fitze; Hans-Detlev Saeger; Christian Pilarsky; Robert Grützmann; Hans K Schackert
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

5.  Biological role of anaplastic lymphoma kinase in neuroblastoma.

Authors:  Yuko Osajima-Hakomori; Izumi Miyake; Miki Ohira; Akira Nakagawara; Atsuko Nakagawa; Ryuichi Sakai
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

Review 6.  Growth factors and tyrosine protein kinases in normal and malignant melanocytes.

Authors:  R Halaban
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

7.  Long segment and short segment familial Hirschsprung's disease: variable clinical expression at the RET locus.

Authors:  P Edery; A Pelet; L M Mulligan; L Abel; T Attié; E Dow; D Bonneau; A David; W Flintoff; D Jan
Journal:  J Med Genet       Date:  1994-08       Impact factor: 6.318

8.  An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway.

Authors:  M Santoro; W T Wong; P Aroca; E Santos; B Matoskova; M Grieco; A Fusco; P P di Fiore
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

9.  Molecular challenges of neuroendocrine tumors.

Authors:  Parthik Patel; Karina Galoian
Journal:  Oncol Lett       Date:  2017-12-21       Impact factor: 2.967

10.  Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations.

Authors:  N Asai; T Iwashita; M Matsuyama; M Takahashi
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.